Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
PLoS One. 2012;7(1):e30079. doi: 10.1371/journal.pone.0030079. Epub 2012 Jan 12.
The first line of defense by bacteria against β-lactam antibiotics is the expression of β-lactamases, which cleave the amide bond of the β-lactam ring. In the reaction of biapenem inactivation by B2 metallo β-lactamases (MβLs), after the β-lactam ring is opened, the carboxyl group generated by the hydrolytic process and the hydroxyethyl group (common to all carbapenems) rotate around the C5-C6 bond, assuming a new position that allows a proton transfer from the hydroxyethyl group to C2, and a nucleophilic attack on C3 by the oxygen atom of the same side-chain. This process leads to the formation of a bicyclic compound, as originally observed in the X-ray structure of the metallo β-lactamase CphA in complex with product.
METHODOLOGY/PRINCIPAL FINDINGS: QM/MM and metadynamics simulations of the post-hydrolysis steps in solution and in the enzyme reveal that while the rotation of the hydroxyethyl group can occur in solution or in the enzyme active site, formation of the bicyclic compound occurs primarily in solution, after which the final product binds back to the enzyme. The calculations also suggest that the rotation and cyclization steps can occur at a rate comparable to that observed experimentally for the enzymatic inactivation of biapenem only if the hydrolysis reaction leaves the N4 nitrogen of the β-lactam ring unprotonated.
CONCLUSIONS/SIGNIFICANCE: The calculations support the existence of a common mechanism (in which ionized N4 is the leaving group) for carbapenems hydrolysis in all MβLs, and suggest a possible revision of mechanisms for B2 MβLs in which the cleavage of the β-lactam ring is associated with or immediately followed by protonation of N4. The study also indicates that the bicyclic derivative of biapenem has significant affinity for B2 MβLs, and that it may be possible to obtain clinically effective inhibitors of these enzymes by modification of this lead compound.
细菌对抗β-内酰胺类抗生素的第一道防线是表达β-内酰胺酶,β-内酰胺酶裂解β-内酰胺环的酰胺键。在比阿培南被 B2 金属β-内酰胺酶(MβL)失活的反应中,β-内酰胺环被打开后,水解过程中产生的羧基和羟乙基基团(所有碳青霉烯类药物的共有基团)围绕 C5-C6 键旋转,假设一个新的位置,允许羟乙基基团的质子转移到 C2,以及同侧链氧原子对 C3 的亲核攻击。这个过程导致形成一个双环化合物,正如最初在与产物结合的金属β-内酰胺酶 CphA 的 X 射线结构中观察到的那样。
方法/主要发现:在溶液中和酶中的水解后步骤的 QM/MM 和元动力学模拟表明,虽然羟乙基基团的旋转可以在溶液中或酶活性部位中发生,但双环化合物的形成主要发生在溶液中,之后最终产物重新结合回酶。计算还表明,只有水解反应使β-内酰胺环的 N4 氮保持未质子化时,旋转和环化步骤的速率才能与实验观察到的比阿培南酶失活速率相媲美。
结论/意义:计算支持所有 MβL 中β-内酰胺类水解的共同机制(其中离子化的 N4 是离去基团)的存在,并建议对 B2 MβL 机制进行可能的修正,其中β-内酰胺环的裂解与 N4 的质子化相关或紧随其后。该研究还表明,比阿培南的双环衍生物对 B2 MβL 具有显著的亲和力,并且通过修饰该先导化合物,可能获得对这些酶具有临床疗效的抑制剂。